| 2026 |
| 10/06 | 6,500 | 7,020 | 6,370 | 6,500 | -1.22% | 357,500 | - | +12.53% |
| 10/05 | 6,510 | 6,770 | 6,460 | 6,580 | +5.11% | 300,200 | - | +14.45% |
| 10/02 | 6,180 | 6,650 | 6,180 | 6,260 | +1.62% | 287,800 | - | +9.71% |
| 10/01 | 6,660 | 6,880 | 6,060 | 6,160 | -7.23% | 521,900 | - | +8.55% |
| 09/30 | 6,640 | 6,640 | 6,570 | 6,640 | +17.73% | 137,500 | - | +17.77% |
| 09/29 | 16:30 再生医療等製品「リハート」第１例目の移植実施に関するお知らせ |
| 09/29 | 5,670 | 5,680 | 5,470 | 5,640 | -1.57% | 60,500 | - | +1.08% |
| 09/28 | 15:30 第三者割当による新株式の発行に係る払込完了に関するお知らせ |
| 09/28 | 5,930 | 5,940 | 5,690 | 5,730 | -3.37% | 81,100 | - | +2.96% |
| 09/25 | 5,930 | 5,990 | 5,830 | 5,930 | +0.68% | 79,800 | - | +7.19% |
| 09/24 | 5,850 | 5,950 | 5,810 | 5,890 | +1.2% | 71,600 | - | +7.07% |
| 09/18 | 5,820 | 5,940 | 5,730 | 5,820 | +0.69% | 91,700 | - | +6.22% |
| 09/17 | 5,680 | 5,870 | 5,650 | 5,780 | +2.66% | 69,900 | - | +5.82% |
| 09/16 | 5,870 | 5,930 | 5,620 | 5,630 | -1.92% | 108,100 | - | +3.45% |
| 09/15 | 5,780 | 5,880 | 5,640 | 5,740 | -1.37% | 79,100 | - | +5.83% |
| 09/14 | 5,360 | 5,890 | 5,310 | 5,820 | +10.65% | 183,600 | - | +7.56% |
| 09/11 | 16:00 第三者割当による新株式の発行及び第1回無担保普通社債の発行に関する補足説明資料 |
| 09/11 | 16:00 第三者割当による新株式の発行に関するお知らせ |
| 09/11 | 5,190 | 5,290 | 5,150 | 5,260 | -1.13% | 47,700 | - | -2.19% |
| 09/10 | 5,290 | 5,320 | 5,220 | 5,320 | +0.19% | 42,700 | - | -0.82% |
| 09/09 | 5,400 | 5,400 | 5,280 | 5,310 | -2.03% | 46,800 | - | -0.73% |
| 09/08 | 5,370 | 5,550 | 5,310 | 5,420 | +0.93% | 56,800 | - | +1.76% |
| 09/07 | 5,320 | 5,450 | 5,260 | 5,370 | 0% | 47,700 | - | +1.51% |
| 09/04 | 5,380 | 5,410 | 5,220 | 5,370 | +1.32% | 61,200 | - | +2.19% |
| 09/03 | 5,360 | 5,450 | 5,260 | 5,300 | -2.39% | 67,200 | - | +1.79% |
| 09/02 | 5,660 | 5,700 | 5,380 | 5,430 | -4.57% | 102,400 | - | +5.15% |
| 09/01 | 15:10 リハートの保険収載に関するお知らせ |
| 09/01 | 5,760 | 5,800 | 5,610 | 5,690 | -1.9% | 111,500 | - | +11.31% |
| 08/31 | 5,950 | 5,950 | 5,730 | 5,800 | -3.33% | 111,300 | - | +14.69% |
| 08/28 | 5,930 | 6,110 | 5,870 | 6,000 | +2.74% | 160,600 | - | +20.17% |
| 08/27 | 5,510 | 5,900 | 5,450 | 5,840 | +6.38% | 156,500 | - | +18.03% |
| 08/26 | 5,540 | 5,780 | 5,490 | 5,490 | 0% | 109,500 | - | +12.45% |
| 08/25 | 5,230 | 5,490 | 5,170 | 5,490 | +4.57% | 87,000 | - | +13.22% |
| 08/24 | 5,250 | 5,370 | 5,210 | 5,250 | +1.16% | 65,200 | - | +9.26% |
| 08/21 | 5,220 | 5,220 | 5,030 | 5,190 | -1.33% | 79,200 | - | +8.69% |
| 08/20 | 4,910 | 5,280 | 4,900 | 5,260 | +7.13% | 128,000 | - | +10.64% |
| 08/19 | 4,965 | 5,100 | 4,840 | 4,910 | -4.47% | 130,400 | - | +3.74% |
| 08/18 | 5,400 | 5,410 | 5,100 | 5,140 | -3.93% | 115,200 | - | +8.81% |
| 08/17 | 5,430 | 5,650 | 5,240 | 5,350 | -0.93% | 167,200 | - | +13.56% |
| 08/14 | 5,150 | 5,500 | 5,040 | 5,400 | +2.27% | 158,000 | - | +15.34% |
| 08/13 | 15:30 2027年3月期第1四半期決算説明資料 |
| 08/13 | 15:30 2027年3月期第1四半期決算短信〔日本基準〕(連結) |
| 08/13 | 5,170 | 5,340 | 5,150 | 5,280 | +1.93% | 109,000 | - | +13.6% |
| 08/12 | 5,350 | 5,350 | 5,080 | 5,180 | -4.07% | 119,700 | - | +12.07% |
| 08/10 | 5,020 | 5,490 | 5,020 | 5,400 | +7.78% | 156,500 | - | +17.16% |
| 08/07 | 4,850 | 5,020 | 4,825 | 5,010 | +2.45% | 70,800 | - | +9.41% |
| 08/06 | 4,945 | 4,955 | 4,825 | 4,890 | -1.11% | 69,000 | - | +7.38% |
| 08/05 | 4,710 | 5,020 | 4,670 | 4,945 | +4.44% | 112,200 | - | +9.19% |
| 08/04 | 4,540 | 4,795 | 4,520 | 4,735 | +4.41% | 110,500 | - | +5.11% |
| 08/03 | 4,345 | 4,605 | 4,300 | 4,535 | +1.11% | 99,800 | - | +1.02% |
| 07/31 | 4,180 | 4,515 | 4,180 | 4,485 | +7.55% | 123,000 | - | +0.52% |
| 07/30 | 4,200 | 4,255 | 4,120 | 4,170 | -1.53% | 90,700 | - | -6.06% |
| 07/29 | 4,340 | 4,355 | 4,160 | 4,235 | +2.54% | 120,900 | - | -4.19% |
| 07/28 | 16:45 通期連結業績予想の上方修正に関するお知らせ |
| 07/28 | 4,250 | 4,295 | 4,090 | 4,130 | -4.4% | 115,500 | - | -6.18% |
| 07/27 | 4,200 | 4,360 | 4,125 | 4,320 | +3.1% | 126,900 | - | -1.75% |
| 07/24 | 4,885 | 5,030 | 4,190 | 4,190 | -14.23% | 482,500 | - | -4.29% |
| 07/23 | 4,605 | 4,885 | 4,580 | 4,885 | +16.73% | 126,300 | - | +11.71% |
| 07/22 | 12:20 リハートの保険償還価格の決定について |
| 07/22 | 4,705 | 4,710 | 4,145 | 4,185 | -10.1% | 608,100 | - | -3.48% |
| 07/21 | 4,450 | 4,675 | 4,435 | 4,655 | +5.8% | 86,000 | - | +7.75% |
| 07/17 | 4,480 | 4,490 | 4,295 | 4,400 | -2.33% | 97,500 | - | +2.64% |
| 07/16 | 4,665 | 4,770 | 4,505 | 4,505 | -3.33% | 84,600 | - | +5.65% |
| 07/15 | 4,720 | 4,745 | 4,605 | 4,660 | -1.27% | 62,900 | - | +10.14% |
| 07/14 | 4,670 | 4,750 | 4,590 | 4,720 | +0.43% | 83,300 | - | +12.22% |
| 07/14 | 8:00 当社取締役 澤芳樹が政府主催「創薬力向上のための官民協議会」への出席に関するお知らせ |
| 07/13 | 4,745 | 4,980 | 4,675 | 4,700 | -2.19% | 93,000 | - | +12.47% |
| 07/10 | 4,670 | 4,895 | 4,565 | 4,805 | +4% | 112,400 | - | +15.64% |
| 07/09 | 4,435 | 4,665 | 4,360 | 4,620 | +1.32% | 109,100 | - | +11.73% |
| 07/08 | 4,690 | 4,800 | 4,510 | 4,560 | -1.72% | 109,000 | - | +10.76% |
| 07/07 | 4,800 | 4,875 | 4,615 | 4,640 | -4.13% | 136,600 | - | +12.92% |
| 07/06 | 4,835 | 4,965 | 4,780 | 4,840 | +3.97% | 216,800 | - | +18.11% |
| 07/03 | 4,450 | 4,655 | 4,410 | 4,655 | +6.16% | 155,900 | - | +13.93% |
| 07/02 | 4,205 | 4,495 | 4,205 | 4,385 | +2.57% | 127,200 | - | +7% |
| 07/01 | 4,250 | 4,305 | 4,090 | 4,275 | -1.16% | 85,100 | - | +3.69% |
| 06/30 | 16:00 投資単位の引下げに関する考え方及び方針等について |
| 06/30 | 16:00 事業計画及び成長可能性に関する事項 |
| 06/30 | 4,590 | 4,590 | 4,220 | 4,325 | -0.57% | 165,000 | - | +3.97% |
| 06/29 | 16:00 国際学会「BCVS 2026」での発表内容が日本からの最高評価アワードを受賞、および「第8回 ACS」にて招待講演（最終演者）に選出のお知らせ |
| 06/29 | 4,085 | 4,375 | 4,085 | 4,350 | +12.84% | 186,600 | - | +3.87% |
| 06/26 | 3,840 | 3,905 | 3,765 | 3,855 | -1.15% | 49,900 | - | -8.65% |
| 06/25 | 3,730 | 3,915 | 3,710 | 3,900 | +4.98% | 94,600 | - | -8.67% |
| 06/24 | 3,755 | 3,820 | 3,700 | 3,715 | -1.72% | 76,300 | - | -14.02% |
| 06/23 | 3,950 | 3,950 | 3,765 | 3,780 | -5.26% | 107,000 | - | -13.7% |
| 06/22 | 3,860 | 4,075 | 3,860 | 3,990 | +3.37% | 91,100 | - | -10.24% |
| 06/19 | 4,060 | 4,060 | 3,845 | 3,860 | -4.81% | 95,100 | - | -14.37% |
| 06/18 | 3,900 | 4,095 | 3,880 | 4,055 | +2.4% | 95,900 | - | -11.94% |
| 06/17 | 3,760 | 4,065 | 3,735 | 3,960 | +4.76% | 112,600 | - | -15.69% |
| 06/16 | 3,850 | 3,925 | 3,725 | 3,780 | -1.31% | 90,100 | - | -21.35% |
| 06/15 | 4,000 | 4,080 | 3,815 | 3,830 | -0.13% | 110,700 | - | -21.96% |
| 06/12 | 3,695 | 3,855 | 3,650 | 3,835 | +3.93% | 172,600 | - | -23.5% |
| 06/11 | 3,875 | 3,875 | 3,610 | 3,690 | -8.09% | 276,200 | - | -27.85% |
| 06/10 | 15:00 2026年3月期決算説明資料 |
| 06/10 | 4,070 | 4,080 | 3,910 | 4,015 | -1.11% | 115,200 | - | -23.07% |
| 06/09 | 4,095 | 4,230 | 4,005 | 4,060 | -0.85% | 123,900 | - | -23.73% |
| 06/08 | 4,165 | 4,230 | 4,040 | 4,095 | -4.66% | 161,800 | - | -24.54% |
| 06/05 | 4,120 | 4,470 | 4,115 | 4,295 | +2.75% | 150,400 | - | -22.4% |
| 06/04 | 4,325 | 4,390 | 4,180 | 4,180 | -4.24% | 94,300 | - | -25.81% |
| 06/03 | 4,280 | 4,420 | 4,060 | 4,365 | +0.34% | 185,600 | - | -24.03% |
| 06/02 | 4,435 | 4,435 | 4,230 | 4,350 | -4.61% | 246,400 | - | -25.68% |
| 06/01 | 4,955 | 4,960 | 4,550 | 4,560 | -7.97% | 218,000 | - | -23.52% |
| 05/29 | 5,000 | 5,080 | 4,920 | 4,955 | -0.9% | 68,500 | - | -18.25% |
| 05/28 | 5,170 | 5,260 | 4,890 | 5,000 | -4.03% | 135,800 | - | -18.61% |
| 05/27 | 5,000 | 5,330 | 4,965 | 5,210 | +3.99% | 115,000 | - | -16.31% |
| 05/26 | 19:30 役員の異動に関するお知らせ |
| 05/26 | 19:30 本店移転及び定款の一部変更に関するお知らせ |
| 05/26 | 19:30 会計監査人の異動に関するお知らせ |
| 05/26 | 5,150 | 5,200 | 4,965 | 5,010 | -2.72% | 99,600 | - | -20.5% |
| 05/25 | 5,070 | 5,150 | 4,820 | 5,150 | +0.59% | 228,600 | - | -19.34% |
| 05/22 | 5,230 | 5,240 | 5,070 | 5,120 | -0.97% | 111,900 | - | -20.77% |
| 05/21 | 5,280 | 5,290 | 5,050 | 5,170 | -0.19% | 135,700 | - | -20.85% |
| 05/20 | 5,390 | 5,390 | 5,040 | 5,180 | -4.07% | 185,200 | - | -21.59% |
| 05/19 | 5,670 | 5,730 | 5,250 | 5,400 | -3.23% | 183,000 | - | -19.23% |
| 05/18 | 14:10 米国心臓協会（AHA）主催の国際学会「BCVS 2026」に当社研究成果に関する演題が採択決定 |
| 05/18 | 6,200 | 6,270 | 5,420 | 5,580 | -11.15% | 297,800 | - | -17.42% |
| 05/15 | 15:30 2026年3月期決算短信〔日本基準〕(連結) |
| 05/15 | 6,350 | 6,420 | 6,170 | 6,280 | -1.1% | 83,500 | - | -7.86% |
| 05/14 | 6,690 | 6,700 | 6,300 | 6,350 | -5.08% | 98,700 | - | -7.2% |
| 05/13 | 6,370 | 6,730 | 6,370 | 6,690 | +5.69% | 97,300 | - | -2.56% |
| 05/12 | 21:30 Nakanoshima Qross Innovation Challenge 採択のお知らせ |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
